Humana Inc. (HUM) Forecast

HUM shows mixed technical signals with elevated valuation concerns. The stock recovered +8.0% from Sept 22 lows ($372) to current $402.27, suggesting short-term momentum. However, the PE ratio of 38.1x is significantly above healthcare sector averages (~20-25x), indicating stretched valuations. Recent price action shows volatility with a -6.3% decline from Sept 11 peak ($409.80), and the stock remains below that resistance level. Volume patterns are inconsistent, peaking during downtrend days (Sept 18: 1.68M shares), suggesting potential distribution. While the recent bounce from support near $372-378 is constructive, the elevated P/E multiple, lack of breakout above Sept 11 highs, and near-term resistance around $410 warrant caution. Current price recovery appears partially corrective rather than fundamentally driven. Recommend waiting for either: (1) confirmation above $410 with strong earnings support, or (2) better entry point if pullback resumes toward $375-385 range.